Seligmann JF, Elliott F, Richman S, Hemmings G, et al. Clinical and molecular characteristics and treatment outcomes of advanced right-colon, left-colon and rectal cancers: data from 1180 patients in a phase III trial of panitumumab with an extended biomarker panel. Ann Oncol 2020;31:1021-1029.
PMID: 32387453